Jim Cramer Recently Looked At These 16 Stocks

Page 7 of 15

9. Dynavax Technologies Corporation (NASDAQ:DVAX)

Number of Hedge Fund Holders: 40

Dynavax Technologies Corporation (NASDAQ:DVAX) is one of the stocks Jim Cramer recently looked at. When a caller noted that they bought the stock three years ago for around $12, Cramer remarked:

“Congratulations. You know that one’s done. They got that nice bid from Sanofi. I’m going to actually go out there and talk to them about that… Well played, my friend.”

Dynavax Technologies Corporation (NASDAQ:DVAX) is a biopharmaceutical company that creates and sells advanced vaccines, including a specialized shot for hepatitis B and a unique additive used to boost immune responses. On December 24, Sanofi (NASDAQ:SNY) announced that it is acquiring the company for nearly $2.2 billion. The deal involves a cash tender offer of $15.50 per share. The CEO of Dynavax Technologies Corporation (NASDAQ:DVAX), Ryan Spencer, commented:

“We believe Sanofi’s commercial reach, development capabilities and commitment to evidence-based immunization will amplify the opportunity for HEPLISAV-B and our innovative pipeline to address important public health needs, further advancing our mission to help protect the world against infectious disease. We are confident that this transaction – and the compelling value it provides – is in the best interests of the Company and its stockholders.”

Page 7 of 15